Literature DB >> 7556446

Modulation of ras transformation affecting chromatin supraorganization as assessed by image analysis.

M L Mello1, S Contente, B C Vidal, W Planding, U Schenck.   

Abstract

Changes in chromatin supraorganization defined in terms of patterns of chromatin texture were studied by video image analysis in Feulgen-stained revertants of LTR-ras-transformed NIH 3T3 cells and in cell lines obtained by transfection of these revertants with sense and antisense constructs of the lysyl oxidase gene (also named Lox or "ras recision gene"). The objective was to determine whether changes in expression of the Lox gene, which have been assumed to modulate cell transformation by ras, could also affect the chromatin supraorganization changes known to be elicited in NIH 3T3 cells by ras transformation. The image analysis results revealed that, although a nuclear phenotype visually similar to the most frequent one (III) in ras-transformed NIH 3T3 cells also appeared in the revertant, it contained a remarkably less tight chromatin packing state. This situation was also found in the revertant transfected with the sense construct of the Lox gene, but in the revertant transfected with the Lox antisense constructs the chromatin texture of the III phenotype was equal to or close to that of the ras-transformed cells. With regard to the nuclear phenotype characterized by abundant loosely packed chromatin and less represented in the transformed cell lines (I'), changes in the various cell lines, although detectable, were not as drastic as those reported for the III phenotype. The enhancement in chromatin condensation of the type III nuclei, which affects euchromatin, is probably associated with a limited transcription of the genome. Although the image analysis results are mostly in agreement with previously published data on the molecular biology and tumorigenicity of the same cell lines, it appears that the phenomenon of chromatin condensation once established in NIH 3T3 cells by LTR-ras transformation could not be totally reverted by simply affecting Lox expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7556446     DOI: 10.1006/excr.1995.1328

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  19 in total

1.  Nuclear chromatin texture and sensitivity to DNase I in human leukaemic CEM cells incubated with nanomolar okadaic acid.

Authors:  S Yatouji; F Liautaud-Roger; J Dufer
Journal:  Cell Prolif       Date:  2000-02       Impact factor: 6.831

Review 2.  Characterizing a human lysyl oxidase chromosomal domain.

Authors:  R P Martins; S A Krawetz
Journal:  Mol Biotechnol       Date:  2000-07       Impact factor: 2.695

3.  Localization and activity of lysyl oxidase within nuclei of fibrogenic cells.

Authors:  W Li; K Nellaiappan; T Strassmaier; L Graham; K M Thomas; H M Kagan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-11-25       Impact factor: 11.205

4.  The lysyl oxidases LOX and LOXL2 are necessary and sufficient to repress E-cadherin in hypoxia: insights into cellular transformation processes mediated by HIF-1.

Authors:  Ruth Schietke; Christina Warnecke; Ingrid Wacker; Johannes Schödel; David R Mole; Valentina Campean; Kerstin Amann; Margarete Goppelt-Struebe; Jürgen Behrens; Kai-Uwe Eckardt; Michael S Wiesener
Journal:  J Biol Chem       Date:  2009-12-21       Impact factor: 5.157

5.  Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03.

Authors:  Quynh-Thu Le; Jonathan Harris; Anthony M Magliocco; Christina S Kong; Roman Diaz; Brian Shin; Hongbin Cao; Andy Trotti; Janine T Erler; Christine H Chung; Adam Dicker; Thomas F Pajak; Amato J Giaccia; K Kian Ang
Journal:  J Clin Oncol       Date:  2009-08-10       Impact factor: 44.544

Review 6.  Lysyl oxidase: a potential target for cancer therapy.

Authors:  V M Berlin Grace; C Guruvayoorappan
Journal:  Inflammopharmacology       Date:  2010-11-24       Impact factor: 4.473

7.  Cloning and characterization of a fourth human lysyl oxidase isoenzyme.

Authors:  J M Mäki; K I Kivirikko
Journal:  Biochem J       Date:  2001-04-15       Impact factor: 3.857

8.  Mural granulosa cell gene expression associated with oocyte developmental competence.

Authors:  Jin-Yi Jiang; Huiling Xiong; Mingju Cao; Xuhua Xia; Marc-Andre Sirard; Benjamin K Tsang
Journal:  J Ovarian Res       Date:  2010-03-06       Impact factor: 4.234

Review 9.  The rationale for targeting the LOX family in cancer.

Authors:  Holly E Barker; Thomas R Cox; Janine T Erler
Journal:  Nat Rev Cancer       Date:  2012-07-19       Impact factor: 60.716

10.  The lysyl oxidase inhibitor, beta-aminopropionitrile, diminishes the metastatic colonization potential of circulating breast cancer cells.

Authors:  Alla Bondareva; Charlene M Downey; Fabio Ayres; Wei Liu; Steven K Boyd; Benedikt Hallgrimsson; Frank R Jirik
Journal:  PLoS One       Date:  2009-05-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.